Quince Therapeutics, Inc. - Common Stock, par value $0.001 per share (QNCX)

CUSIP: 22053A107

Q1 2021 13F Holders as of 31 Mar 2021

Holder snapshot 7 signals
Share change
+984,429
Put/Call ratio
128%
SEC-reported price per share
$36.03
Number of holders
90
Value change
+$37,011,077
Number of buys
40
Open additional details 1 more signal available
Number of sells
37
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
60,216,782

Security key

22053A107

Report period

Q1 2021

Institutions

90

Top holders

10

Ownership snapshot

Top reported holders of QNCX - Quince Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
EPIQ Capital Group, LLC
Disclosed value leader
EPIQ Capital Group, LLC
Comparable rows
15/15
Latest evidence
31 Dec 2020
13F Lead comparable stake: 5.8% Showing 1-6 of 15 holder rows.

Quick read

EPIQ Capital Group, LLC leads the comparable SEC ownership view at 5.8%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens EPIQ Capital Group, LLC's linked filing trail.
Comparable ownership Top 5
EPIQ Capital Group, LLC 5.8%
Capital World Investors 4.3%
Capital Research Global Investors 4.3%
Capital International Investors 4.3%
BlackRock Finance, Inc. 2.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
EPIQ Capital Group, LLC
13F
Company
13F
5.8%
$97,427,000
3,507,082 shares
31 Dec 2020
Capital World Investors
13F
Company
13F
4.3%
$72,512,000
2,610,237 shares
31 Dec 2020
Capital Research Global Investors
13F
Company
13F
4.3%
$72,388,000
2,605,753 shares
31 Dec 2020
Capital International Investors
13F
Company
13F
4.3%
$71,685,000
2,580,455 shares
31 Dec 2020
BlackRock Finance, Inc.
13F
Company
13F
2.3%
$37,841,000
1,362,139 shares
31 Dec 2020
SC US (TTGP), LTD.
13F
Company
13F
1.7%
$28,901,000
1,040,343 shares
31 Dec 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
90
Shares
18,693,040
Rows available
90
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders
84
Q1 2021 holders
90
Holder diff
6
Investor Q4 2020 Shares Q1 2021 Shares Share Diff Share Chg % Q4 2020 value Q1 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .